24 May 2013
Keywords: cytos, candidate, hypertension, vaccine, cuts, morning, bp
Article | 17 March 2008
Switzerland-based Cytos Biotechnology AG says that data from a trial of
a developmental hypertension vaccine, CYT006-AngQb, indicate that the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 March 2008
24 March 2008
10 March 2008
© 2013 thepharmaletter.com